Published in J Virol on July 01, 2015
Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material. Viruses (2015) 0.87
Deaths, late deaths, and role of infecting dose in Ebola virus disease in Sierra Leone: retrospective cohort study. BMJ (2016) 0.83
Assessment of Environmental Contamination and Environmental Decontamination Practices within an Ebola Holding Unit, Freetown, Sierra Leone. PLoS One (2015) 0.83
Pathogenicity Comparison Between the Kikwit and Makona Ebola Virus Variants in Rhesus Macaques. J Infect Dis (2016) 0.78
Chasing Ebola through the Endosomal Labyrinth. MBio (2016) 0.76
Validation of the Filovirus Plaque Assay for Use in Preclinical Studies. Viruses (2016) 0.75
Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. N Engl J Med (2014) 28.65
The Identification and Characterization of Bacteriophages with the Electron Microscope. Proc Natl Acad Sci U S A (1942) 17.02
Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med (2014) 16.45
Rapid evolution of RNA genomes. Science (1982) 14.76
Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog (2008) 6.07
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol (2003) 4.67
Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis (1997) 4.03
Basic concepts in RNA virus evolution. FASEB J (1996) 3.35
New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule. Fed Regist (2002) 3.07
Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology (1983) 3.04
Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg (2010) 2.92
Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule. Nat Rev Microbiol (2009) 2.71
Molecular biology of rubella virus. Adv Virus Res (1994) 2.55
A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis (1999) 2.24
Infection and activation of monocytes by Marburg and Ebola viruses. J Virol (2001) 1.90
The pathology of experimental Ebola virus infection in monkeys. J Pathol (1978) 1.66
Ebola Reston virus infection of pigs: clinical significance and transmission potential. J Infect Dis (2011) 1.58
Animal models for Ebola and Marburg virus infections. Front Microbiol (2013) 1.51
Host alternation of chikungunya virus increases fitness while restricting population diversity and adaptability to novel selective pressures. J Virol (2010) 1.51
The ratio of physical particles per infectious unit observed for poliomyelitis viruses. Virology (1957) 1.43
The FDA animal efficacy rule and biodefense. Nat Biotechnol (2007) 1.43
The organisation of Ebola virus reveals a capacity for extensive, modular polyploidy. PLoS One (2012) 1.43
Enumeration of an extremely high particle-to-PFU ratio for Varicella-zoster virus. J Virol (2009) 1.33
Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection. PLoS One (2012) 1.28
Reston ebolavirus in humans and animals in the Philippines: a review. J Infect Dis (2011) 1.20
Incidences and range of spontaneous findings in control cynomolgus monkeys (Macaca fascicularis) used in toxicity studies. Toxicol Pathol (2010) 1.19
Quantitative analysis of particles, genomes and infectious particles in supernatants of haemorrhagic fever virus cell cultures. Virol J (2011) 1.16
Population dynamics of an RNA virus and its defective interfering particles in passage cultures. Virol J (2010) 1.12
Ebola virus defective interfering particles and persistent infection. Virology (1999) 1.03
Standardization of the filovirus plaque assay for use in preclinical studies. Viruses (2012) 0.99
How do filovirus filaments bend without breaking? Trends Microbiol (2013) 0.94
"Filoviruses": a real pandemic threat? EMBO Mol Med (2009) 0.88
Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nat Biotechnol (2002) 2.77
Prediction and identification of herpes simplex virus 1-encoded microRNAs. J Virol (2006) 2.67
Spontaneous heart disease in the adult chimpanzee (Pan troglodytes). J Med Primatol (2008) 1.72
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol (2012) 1.59
Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin Vaccine Immunol (2006) 1.50
Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons. Proc Natl Acad Sci U S A (2009) 1.45
A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses. J Virol (2005) 1.42
Hyperbaric oxygen treatment prevents up-regulation of angiogenesis following partial-thickness skin grafts in the pig. Wound Repair Regen (2003) 1.41
Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues. J Virol (2007) 1.41
A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PLoS One (2013) 1.38
Spontaneous neoplasia in the baboon (Papio spp.). J Med Primatol (2007) 1.34
Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region. Infect Immun (2005) 1.28
The pathogenesis of Rift Valley fever virus in the mouse model. Virology (2010) 1.28
Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013. Arch Virol (2014) 1.27
Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques. J Infect Dis (2011) 1.26
Biomedical differences between human and nonhuman hominids: potential roles for uniquely human aspects of sialic acid biology. Annu Rev Pathol (2011) 1.25
Productive replication of Ebola virus is regulated by the c-Abl1 tyrosine kinase. Sci Transl Med (2012) 1.24
Protection against lethal challenge by Ebola virus-like particles produced in insect cells. Virology (2008) 1.22
Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Arch Virol (2013) 1.16
A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. Vaccine (2007) 1.13
Filoviruses utilize glycosaminoglycans for their attachment to target cells. J Virol (2013) 1.11
Potential impact of a 2-person security rule on BioSafety Level 4 laboratory workers. Emerg Infect Dis (2009) 1.11
Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Arch Virol (2013) 1.10
Common marmosets (Callithrix jacchus) as a nonhuman primate model to assess the virulence of eastern equine encephalitis virus strains. J Virol (2008) 1.10
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates. Vaccine (2008) 1.09
The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment. Viruses (2012) 1.08
A novel Brucella isolate in association with two cases of stillbirth in non-human primates - first report. J Med Primatol (2009) 1.07
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. Virology (2006) 1.06
A small nonhuman primate model for filovirus-induced disease. Virology (2011) 1.03
Rapid assembly of sensitive antigen-capture assays for Marburg virus, using in vitro selection of llama single-domain antibodies, at biosafety level 4. J Infect Dis (2007) 1.02
Let-7 microRNAs are developmentally regulated in circulating human erythroid cells. J Transl Med (2009) 1.01
Short report: quantification of leishmaniavirus RNA in clinical samples and its possible role in pathogenesis. Am J Trop Med Hyg (2003) 1.00
Application of a granular mineral-based hemostatic agent (QuikClot) to reduce blood loss after grade V liver injury in swine. J Trauma (2004) 0.99
Standardization of the filovirus plaque assay for use in preclinical studies. Viruses (2012) 0.99
RNA binding domain of Jamestown Canyon virus S segment RNAs. J Virol (2007) 0.99
Spontaneous pathology of the common marmoset (Callithrix jacchus) and tamarins (Saguinus oedipus, Saguinus mystax). J Med Primatol (2009) 0.98
A novel adenovirus species associated with an acute respiratory outbreak in a baboon colony and evidence of coincident human infection. MBio (2013) 0.98
Acute respiratory distress syndrome secondary to inhalation of chlorine gas in sheep. J Trauma (2006) 0.98
Comparison of hemorrhage control agents applied to lethal extremity arterial hemorrhages in swine. J Trauma (2005) 0.97
Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys. Clin Vaccine Immunol (2009) 0.97
The frequency of lymphocytic and reflux esophagitis in non-human primates. Int J Clin Exp Pathol (2008) 0.97
Natural Chagas disease in four baboons. J Med Primatol (2008) 0.97
Natural pathology of the Baboon (Papio spp.). J Med Primatol (2011) 0.96
Trypanosoma cruzi in non-human primates with a history of stillbirths: a retrospective study (Papio hamadryas spp.) and case report (Macaca fascicularis). J Med Primatol (2008) 0.95
The columnar-lined mucosa in the distal esophagus. A preliminary study in baboons. In Vivo (2009) 0.94
Mammalian alphaherpesvirus miRNAs. Biochim Biophys Acta (2011) 0.93
Baboon as a nonhuman primate model for vaccine studies. Vaccine (2005) 0.92
A preliminary report on the feeding of cynomolgus monkeys (Macaca fascicularis) with a high-sugar high-fat diet for 33 weeks. J Med Primatol (2011) 0.92
Pathology of spontaneous air sacculitis in 37 baboons and seven chimpanzees and a brief review of the literature. J Med Primatol (2012) 0.91
An animal model that reflects human disease: the common marmoset (Callithrix jacchus). Curr Opin Virol (2012) 0.91
Identification and expression analysis of herpes B virus-encoded small RNAs. J Virol (2011) 0.91
Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs. Vaccine (2010) 0.90
Discovery of herpes B virus-encoded microRNAs. J Virol (2009) 0.90
The columnar-lined mucosa at the gastroesophageal junction in non-human primates. Int J Clin Exp Pathol (2008) 0.89
Hemostatic efficacy of two advanced dressings in an aortic hemorrhage model in Swine. J Trauma (2005) 0.89
Use of Luminex xMAP-derived Bio-Plex bead-based suspension array for specific detection of PPV W and characterization of epitopes on the coat protein of the virus. J Virol Methods (2008) 0.89
Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection. Am J Trop Med Hyg (2010) 0.88
Herpes B virus utilizes human nectin-1 but not HVEM or PILRα for cell-cell fusion and virus entry. J Virol (2012) 0.88
Nonspecific lymphocytic myocarditis in baboons is associated with Trypanosoma cruzi infection. Am J Trop Med Hyg (2009) 0.88
Polymerase chain reaction detection of Trypanosoma cruzi in Macaca fascicularis using archived tissues. Am J Trop Med Hyg (2009) 0.88
The ontogeny of the endocrine pancreas in the fetal/newborn baboon. J Endocrinol (2012) 0.88
The frequency of gastric amyloidosis in baboons. A 22-year survey at a large primate facility. In Vivo (2009) 0.87
Stillbirths in Macaca fascicularis. J Med Primatol (2008) 0.87
Bovine hemoglobin-based oxygen-carrying solution (HBOC-201) improves flap survival in a rat model of epigastric flap failure. Microsurgery (2006) 0.87
Spontaneous squamous cell carcinomas in 13 baboons, a first report in a spider monkey, and a review of the non-human primate literature. J Med Primatol (2009) 0.87
Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates. PLoS One (2011) 0.87
Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro. J Virol (2012) 0.86
Fatal acute Chagas disease in a chimpanzee. J Med Primatol (2009) 0.85
Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidate. PLoS Negl Trop Dis (2013) 0.85
Further studies on Barretts mucosa in baboons: metaplastic glandular cells produce sialomucin. Anticancer Res (2010) 0.85
Detection of leukocyte activation in pigs with neurologic decompression sickness. Aviat Space Environ Med (2004) 0.84
Mortality in captive baboons (Papio spp.): a-23-year study. J Med Primatol (2014) 0.84
Pathology of the male baboon (Papio spp.) urogenital system. J Med Primatol (2008) 0.84
Myxomatous neoplasms in the perineal region of baboons. J Med Primatol (2008) 0.84
Congenital anomalies in the baboon (Papio spp.). J Med Primatol (2011) 0.84
A simple method to record parietal cells in the fundic mucosa in baboons. In Vivo (2010) 0.83
Efficacy of FDA-approved hemostatic drugs to improve survival and reduce bleeding in rat models of uncontrolled hemorrhage. Resuscitation (2006) 0.83
Incidence of lymphocytic esophagitis in baboons. In Vivo (2008) 0.83
Nonhuman primates as models for studies of prostate specific antigen and prostatic diseases. Prostate (2008) 0.82